Case Report
Copyright ©The Author(s) 2019.
World J Clin Cases. Dec 26, 2019; 7(24): 4355-4365
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4355
Table 4 Clinical characteristics of multisystem smooth muscle dysfunction syndrome patients worldwide
CharacteristicPrabhu et al[15], 2017Logeswaran et al[16], 2017Zhou et al[3], 2017Our patientObserved Cases (n)Positive cases, n (%)
n1211
GenderFMFFF33
Age (yr)0.43 (d)2620.8
Vision systemCongenital mydriasis+++++3333 (100)
Retinal vascular tortuosity+++-1615 (93.8)
Cardiovascular systemPDA++++-3332 (97.0)
ASD-----336 (18.2)
PAH+-++-2713 (48.1)
TAA--+--279 (33.3)
AAD-----279 (33.3)
PAD+-+-+2711 (40.7)
Nervous systemDevelopment delay+++1610 (62.5)
Spastic seizures/epilepsy-53 (60.0)
Cerebral infarction/hemiplegia----325 (15.6)
WM signal changes+++-3223 (71.9)
Moyamoya-like changes-++-3223 (71.9)
Digestive systemIntestinal malrotation----177 (41.2)
Intestinal hypoperistalsis----176 (35.3)
Gallstones--+53 (60.0)
Respiratory systemDyspnea++2315 (65.2)
RRTI++235 (21.7)
Asthma--233 (13.0)
Urinary systemHypotonic bladder--2414 (58.3)
Hydronephrosis---95 (55.6)
Hypospadias---85 (62.5)
ACTA2 mutationHHHHH
Prognosis